Literature DB >> 17348446

Nested case-control study of energy regulation candidate gene single nucleotide polymorphisms and breast cancer.

Yiting Wang1, Marjorie L McCullough, Victoria L Stevens, Carmen Rodriguez, Eric J Jacobs, Lauren R Teras, Alexandre L Pavluck, Michael J Thun, Eugenia E Calle.   

Abstract

BACKGROUND: Accumulating evidence suggests that energy regulation, particularly insulin resistance, may influence breast cancer risk.
MATERIALS AND METHODS: The associations between single nucleotide polymorphisms (SNPs) in energy regulation candidate genes and postmenopausal breast cancer risk were evaluated. Conditional logistic regression was run on 488 matched case-control pairs from the American Cancer Society's Cancer Prevention Study II Nutrition Cohort. The studied SNPs were INS+1127 PstI (rs3842752), INSR H1085H (rs1799817) and PPARy Prol2Ala (rs1801282).
RESULTS: A significantly lower breast cancer risk was found among women homozygous for the T allele of INSR H1085H. A marginally significant increased risk of breast cancer was observed among women homozygous for the Ala allele of PPARgamma Pro12Ala. No significant association was observed between INS+ 1127 PstI and breast cancer risk.
CONCLUSION: Our results suggest that polymorphisms in these energy regulation candidate genes may be associated with risk of breast cancer, but replication in larger studies is needed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17348446

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Genetic variation in peroxisome proliferator-activated receptor gamma, soy, and mammographic density in Singapore Chinese women.

Authors:  Eunjung Lee; Chris Hsu; David Van den Berg; Giske Ursin; Woon-Puay Koh; Jian-Min Yuan; Daniel O Stram; Mimi C Yu; Anna H Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-01       Impact factor: 4.254

2.  Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers.

Authors:  Susan L Neuhausen; Sean Brummel; Yuan Chun Ding; Linda Steele; Katherine L Nathanson; Susan Domchek; Timothy R Rebbeck; Christian F Singer; Georg Pfeiler; Henry T Lynch; Judy E Garber; Fergus Couch; Jeffrey N Weitzel; Andrew Godwin; Steven A Narod; Patricia A Ganz; Mary B Daly; Claudine Isaacs; Olufunmilayo I Olopade; Gail E Tomlinson; Wendy S Rubinstein; Nadine Tung; Joanne L Blum; Daniel L Gillen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-06-27       Impact factor: 4.254

3.  Genetic variation in TNFα, PPARγ, and IRS-1 genes, and their association with breast-cancer survival in the HEAL cohort.

Authors:  Catherine Duggan; Richard N Baumgartner; Kathy B Baumgartner; Leslie Bernstein; Stephanie George; Rachel Ballard; Marian L Neuhouser; Anne McTiernan
Journal:  Breast Cancer Res Treat       Date:  2017-12-18       Impact factor: 4.872

4.  Insulin receptor variants and obesity-related cancers in the Framingham Heart Study.

Authors:  Niyati Parekh; Guia Guffanti; Yong Lin; Heather M Ochs-Balcom; Nour Makarem; Richard Hayes
Journal:  Cancer Causes Control       Date:  2015-06-16       Impact factor: 2.506

5.  Genetic Variants in Metabolic Signaling Pathways and Their Interaction with Lifestyle Factors on Breast Cancer Risk: A Random Survival Forest Analysis.

Authors:  Su Yon Jung; Jeanette C Papp; Eric M Sobel; Zuo-Feng Zhang
Journal:  Cancer Prev Res (Phila)       Date:  2017-10-26

6.  Peroxisome proliferator-activated receptor gamma (PPARG) polymorphisms and breast cancer susceptibility: a meta-analysis.

Authors:  Weifeng Tang; Yuanmei Chen; Yafeng Wang; Haiyong Gu; Shuchen Chen; Mingqiang Kang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  Peroxisome proliferator-activated receptor gamma (PPARG) rs1801282 C>G polymorphism is associated with cancer susceptibility in asians: an updated meta-analysis.

Authors:  Yafeng Wang; Yu Chen; Heping Jiang; Weifeng Tang; Mingqiang Kang; Tianyun Liu; Zengqing Guo; Zhiqiang Ma
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case-Control Study.

Authors:  Esra Unal; Ezgi Irmak Aslan; Tulin Ozturk; Ozlem Kurnaz Gomleksiz; Ozlem Kucukhuseyin; M Bora Tuzuner; M Fatih Seyhan; Oguz Ozturk; Hulya Yilmaz Aydogan
Journal:  Biochem Genet       Date:  2021-04-24       Impact factor: 1.890

9.  PPARγ2 polymorphism and human health.

Authors:  Weimin He
Journal:  PPAR Res       Date:  2009-04-16       Impact factor: 4.964

10.  PPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes.

Authors:  Ancha Baranova
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.